Sofinnova Investments’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Sofinnova Investments’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,341	Closed	-$3.9M	–	71
2019 Q4	$3.9M	Hold	28,341	–	–	0.28%	47
2019 Q3	$3.37M	Sell	28,341 -8,206	-22%	-$1.15M	0.3%	49
2019 Q2	$5.11M	Buy	36,547 +8,939	+32%	+$1.57M	0.47%	39
2019 Q1	$4.94M	Buy	27,608 +5,346	+24%	+$804K	0.48%	40
2018 Q4	$3.5M	Buy	+22,262	New	+$3.32M	0.44%	43

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sofinnova Investments's ORTX Position: Q1 2020 in Review

Sofinnova Investments sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 28,341 shares — an estimated $3.9M sold.

Sofinnova Investments first reported a position in ORTX in Q4 2018 and held it in 5 quarters. The position peaked at $5.11M in Q2 2019. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

Sofinnova Investments reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Sofinnova Investments sold 28,341 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $3.9M.
Sofinnova Investments first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 5 quarters.
Sofinnova Investments's Orchard Therapeutics plc American Depositary Shares position peaked at $5.11M in Q2 2019.
74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Sofinnova Investments's 13F filing for Q1 2020, filed 13 May 2020.